Literature DB >> 21168406

Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma.

Prakash Rath1, Douglas C Miller, N Scott Litofsky, Douglas C Anthony, Qi Feng, Craig Franklin, Lirong Pei, Alan Free, Jimei Liu, Mingqiang Ren, Mark D Kirk, Huidong Shi.   

Abstract

The majority of meningiomas are benign tumors associated with favorable outcomes; however, the less common aggressive variants with unfavorable outcomes often recur and may be due to subpopulations of less-differentiated cells residing within the tumor. These subpopulations of tumor cells have tumor-initiating properties and may be isolated from heterogeneous tumors when sorted or cultured in defined medium. We report the isolation and characterization of a population of tumor-initiating cells derived from an atypical meningioma. We identify a tumor-initiating population from an atypical meningioma, termed meningioma-initiating cells (MICs). These MICs self-renew, differentiate, and can recapitulate the histological characteristics of the parental tumor when transplanted at 1000 cells into the flank regions of athymic nude mice. Immunohistochemistry reveals stem-like protein expression patterns similar to neural stem and progenitor cells (NSPCs) while genomic profiling verified the isolation of cancer cells (with defined meningioma chromosomal aberrations) from the bulk tumor. Microarray and pathway analysis identifies biochemical processes and gene networks related to aberrant cell cycle progression, particularly the loss of heterozygosity of tumor suppressor genes CDKN2A (p16(INK4A)), p14(ARF), and CDKN2B (p15(INK4B)). Flow cytometric analysis revealed the expression of CD44 and activated leukocyte adhesion molecule (ALCAM/CD166); these may prove to be markers able to identify this cell type. The isolation and identification of a tumor-initiating cell population capable of forming meningiomas demonstrates a useful model for understanding meningioma development. This meningioma model may be used to study the cell hierarchy of meningioma tumorogenesis and provide increased understanding of malignant progression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168406      PMCID: PMC3048914          DOI: 10.1016/j.yexmp.2010.12.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  32 in total

1.  Isolation and characterization of tumor stem-like cells from human meningiomas.

Authors:  Dueng-Yuan Hueng; Huey-Kang Sytwu; Shih-Ming Huang; Chen Chang; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

2.  Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Authors:  J Boström; B Meyer-Puttlitz; M Wolter; B Blaschke; R G Weber; P Lichter; K Ichimura; V P Collins; G Reifenberger
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.

Authors:  Mark A Watson; David H Gutmann; Kelly Peterson; Michael R Chicoine; Bette K Kleinschmidt-DeMasters; Henry G Brown; Arie Perry
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Characterization of a subpopulation of colon cancer cells with stem cell-like properties.

Authors:  Peter Chu; Dana J Clanton; Tracey S Snipas; Julia Lee; Eric Mitchell; Mai-Lan Nguyen; Eric Hare; Robert J Peach
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

Review 5.  Die hard: are cancer stem cells the Bruce Willises of tumor biology?

Authors:  Akos Fábián; Márk Barok; György Vereb; János Szöllosi
Journal:  Cytometry A       Date:  2009-01       Impact factor: 4.355

6.  Immunohistochemical study of anaplastic meningioma with special reference to the phenotypic change of intermediate filament protein.

Authors:  Hidetoshi Ikeda; Takashi Yoshimoto
Journal:  Ann Diagn Pathol       Date:  2003-08       Impact factor: 2.090

Review 7.  PTEN, stem cells, and cancer stem cells.

Authors:  Reginald Hill; Hong Wu
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

8.  A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.

Authors:  Theresa A DiMeo; Kristen Anderson; Pushkar Phadke; Cheng Fan; Chang Feng; Charles M Perou; Steven Naber; Charlotte Kuperwasser
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

9.  Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip.

Authors:  Tsutomu Sasaki; Gerald R Hankins; Gregory A Helm
Journal:  Neurosurgery       Date:  2003-04       Impact factor: 4.654

10.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  13 in total

1.  Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.

Authors:  Yanjue Wu; Jean-Philippe Richard; Shervin D Wang; Prakash Rath; John Laterra; Shuli Xia
Journal:  Cancer Sci       Date:  2012-04-04       Impact factor: 6.716

2.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

3.  A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.

Authors:  Fares Nigim; Shin-Ichi Esaki; Michael Hood; Nina Lelic; Marianne F James; Vijaya Ramesh; Anat Stemmer-Rachamimov; Daniel P Cahill; Priscilla K Brastianos; Samuel D Rabkin; Robert L Martuza; Hiroaki Wakimoto
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

Review 4.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  The role of stem cells in benign tumors.

Authors:  Haiyan Qin; Dongyu Bao; Xin Tong; Qingang Hu; Guowen Sun; Xiaofeng Huang
Journal:  Tumour Biol       Date:  2016-09-21

6.  Valproic acid promotes radiosensitization in meningioma stem-like cells.

Authors:  Hsin-Ying Clair Chiou; Wen-Kuo Lai; Li-Chun Huang; Shih-Ming Huang; Sheau-Huei Chueh; Hsin-I Ma; Dueng-Yuan Hueng
Journal:  Oncotarget       Date:  2015-04-30

7.  Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.

Authors:  Ishaq Khan; Saleh Baeesa; Mohammed Bangash; Hans-Juergen Schulten; Fahad Alghamdi; Hanadi Qashqari; Nawal Madkhali; Angel Carracedo; Mohamad Saka; Awatif Jamal; Jaudah Al-Maghrabi; Mohammed AlQahtani; Saleh Al-Karim; Ghazi Damanhouri; Kulvinder Saini; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2017-07-21       Impact factor: 5.722

8.  In situ characterization of stem cells-like biomarkers in meningiomas.

Authors:  Hanin Alamir; Mona Alomari; Abdulla Ahmed A Salwati; Mohamad Saka; Mohammed Bangash; Saleh Baeesa; Fahad Alghamdi; Angel Carracedo; Hans-Juergen Schulten; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2018-05-25       Impact factor: 5.722

9.  An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors.

Authors:  Juan Sebastian Yakisich
Journal:  ISRN Pharmacol       Date:  2012-07-03

10.  EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.

Authors:  Wen-Chiuan Tsai; Ying Chen; Li-Chun Huang; Herng-Sheng Lee; Hsin-I Ma; Shih-Ming Huang; Huey-Kang Sytwu; Dueng-Yuan Hueng
Journal:  J Neurooncol       Date:  2013-07-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.